Article

Drug Spending and Access Limitations Highlight Specialty Pharmacy Week in Review

Author(s):

Davy James, Managing Editor

Top stories of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/drug-spending-and-access-limitations-highlight-spe" target="_blank">View the story "Drug Spending and Access Limitations Highlight Specialty Pharmacy Week in Review" on Storify</a>]

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Lenacapavir | Image Credit: luchschenF | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Related Content
Motor neuron connecting to muscle fiber, 3D illustration
August 30th 2025

Study: Apitegromab Meaningfully Improves Motor Function in Spinal Muscular Atrophy

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
August 30th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Skin disorder, pepper appearance from scleroderma, autoimmune disease male hand Skin disorder pepper appearance from vitiligo,scleroderma raynaud, medical concept autoimmune disease.
August 30th 2025

Patients With Systemic Sclerosis Face Decreased HDL-C, Increased Lipoprotein(a)

Luke Halpern, Assistant Editor
Pharmacy Focus: World Psychedelics Day
August 30th 2025

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
High-density lipoprotein particles(HDL) also known as good cholesterol, in the blood. Higher HDL levels correlate with lower risk of cardiovascular disease
August 30th 2025

Elevated High-Density Lipoprotein Cholesterol May Reduce Risk of Stress Urinary Incontinence

Luke Halpern, Assistant Editor
FDA logo on smartphone -- Image credit: gguy | stock.adobe.com
August 30th 2025

FDA Issues CRL to Vatiquinone NDA Indicated For Friedreich Ataxia

Gillian McGovern, Associate Editor